Expression profile analysis identifies a two-gene signature for prediction of head and neck squamous cell carcinoma patient survival
- PMID: 30589034
- DOI: 10.4103/jcrt.JCRT_557_18
Expression profile analysis identifies a two-gene signature for prediction of head and neck squamous cell carcinoma patient survival
Abstract
Aim: The aim of this study is to identify a gene prognostic signature for the head-and-neck squamous cell carcinoma (HNSCC). HNSCC is one of the most common malignancies worldwide; however, the molecular mechanisms underlying the malignancy are unclear.
Materials and methods: We analyzed the gene expression profiles of GSE2379, GSE53819, and GSE59102 derived from the gene expression omnibus, and the cancer genome atlas (TCGA) HNSC databases. The R software was used to identify the differentially expressed genes (DEGs) between HNSCC tissues and normal controls. Gene ontology, Kyoto Encyclopedia of Genes and Genomes pathway, protein-protein interactions network, and survival analyses of common DEGs were also performed.
Results: A total of 52 upregulated and 31 downregulated DEGs were identified. Functional analyses demonstrated that these DEGs were mainly enriched in extracellular matrix-receptor interaction, focal adhesion, tyrosine metabolism, and cytokine-cytokine receptor interaction. According to the survival analyses, PLAU and SERPINE1 could predict the overall survival of HNSCC patients from the TCGA cohort. Multivariable Cox regression analyses showed that the PLAU and SERPINE1 were independent prognostic factors for HNSCC patients. The prediction power of this two-gene signature was evaluated through receiver operating characteristic curve analysis and achieved a better prognostic value than PLAU (area under curve 0.613 [95% confidence interval 0.569-0.656] vs. 0.577 [0.533-0.621]; P = 0.008) or SERPINE1 (0.613 [0.569-0.656] vs. 0.586 [0.541-0.629]; P = 0.043) when considered alone.
Conclusions: The study has identified a set of novel genes and pathways that play significant roles in the carcinogenesis and progression of HNSCC. This two-gene signature may prove to be a useful therapeutic target for HNSCC.
Keywords: Gene ontology; head-and-neck squamous cell carcinoma; protein-protein interactions network; signature; survival analysis.
Conflict of interest statement
None
Similar articles
-
Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis.Int J Clin Oncol. 2019 Sep;24(9):1030-1041. doi: 10.1007/s10147-019-01435-9. Epub 2019 Apr 1. Int J Clin Oncol. 2019. PMID: 30937621 Free PMC article.
-
A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.Genet Test Mol Biomarkers. 2021 Aug;25(8):517-527. doi: 10.1089/gtmb.2021.0066. Genet Test Mol Biomarkers. 2021. PMID: 34406843 Free PMC article.
-
Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets.Biomed Res Int. 2019 Aug 7;2019:7376034. doi: 10.1155/2019/7376034. eCollection 2019. Biomed Res Int. 2019. PMID: 31485443 Free PMC article.
-
MicroRNA profile in the squamous cell carcinoma: prognostic and diagnostic roles.Heliyon. 2020 Nov 6;6(11):e05436. doi: 10.1016/j.heliyon.2020.e05436. eCollection 2020 Nov. Heliyon. 2020. PMID: 33204886 Free PMC article. Review.
-
Ion Channel Dysregulation in Head and Neck Cancers: Perspectives for Clinical Application.Rev Physiol Biochem Pharmacol. 2021;181:375-427. doi: 10.1007/112_2020_38. Rev Physiol Biochem Pharmacol. 2021. PMID: 32789787 Review.
Cited by
-
Transcriptomics and Epigenomics in head and neck cancer: available repositories and molecular signatures.Cancers Head Neck. 2020 Jan 21;5:2. doi: 10.1186/s41199-020-0047-y. eCollection 2020. Cancers Head Neck. 2020. PMID: 31988797 Free PMC article. Review.
-
Head and Neck Squamous Cell Carcinoma Biopsies Maintained Ex Vivo on a Perfusion Device Show Gene Changes with Time and Clinically Relevant Doses of Irradiation.Cancers (Basel). 2023 Sep 15;15(18):4575. doi: 10.3390/cancers15184575. Cancers (Basel). 2023. PMID: 37760543 Free PMC article.
-
FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma.Biosci Rep. 2021 Jul 30;41(7):BSR20202929. doi: 10.1042/BSR20202929. Biosci Rep. 2021. PMID: 34028536 Free PMC article.
-
Ontologies and Knowledge Graphs in Oncology Research.Cancers (Basel). 2022 Apr 10;14(8):1906. doi: 10.3390/cancers14081906. Cancers (Basel). 2022. PMID: 35454813 Free PMC article. Review.
-
OncomiR miR-182-5p Enhances Radiosensitivity by Inhibiting the Radiation-Induced Antioxidant Effect through SESN2 in Head and Neck Cancer.Antioxidants (Basel). 2021 Nov 14;10(11):1808. doi: 10.3390/antiox10111808. Antioxidants (Basel). 2021. PMID: 34829679 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous